-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Pyxis Oncology, Raises Price Target to $7

Benzinga·11/04/2025 15:37:04
Listen to the news
Guggenheim analyst Brad Canino maintains Pyxis Oncology (NASDAQ:PYXS) with a Buy and raises the price target from $5 to $7.